| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |